Download the ICS Branding Pack
Podium Short Oral Session 26 Urethra & Prostate 493 Is use of a nerve-sparing technique necessary for patients who prioritize recovery of urinary continence over erectile function after radical prostatectomy?
Open Discussion ePoster Session 35 Open Discussion ePosters 3 678 Surgical and patient reported outcomes of artificial urinary sphincter implantation- a multicentre prospective observational study
Non Discussion Abstract Session 41 Non Discussion Abstracts 877 Prospective observational study of predictive clinical parameters in patients with benign prostatic hypertrophy medicated with silodosin for three years
Podium Express Session 22 Rapid Communications in Conservative Management 421 A multicenter prospective observational study to estimate early changes of continence status and quality of life in patients undergoing artificial urinary sphincter implantation
Open Discussion ePoster Session 8 Open Discussion ePoster 100 Prospective observational study of predictive clinical parameters in patients with benign prostatic hypertrophy medicated with silodosin for over one year
Oral ePoster Session 7 Experimental Models and Pharmacology 60 Effects of tadalafil, a phosphodiesterase type 5 inhibitor, on the urethral continence reflex induced by sneezing were investigated.
Non Discussion Abstract Session 35 Read By Title 754 Urinary straining leads to inguinal hernia after radical retropubic prostatectomy.
Non Discussion Poster Session 29 395 Effects of PDE5i administration immediately after nerve-sparing radical prostatectomy on postoperative recovery of urinary continence
Podium Poster Session 4 Male LUTS, Clinical and Basic Science 20 The effects of type 5 phosphodiesterase inhibitors on the recovery of urinary continence after radical prostatectomy
Non Discussion Poster Session 32 374 The effects of type 5 phosphodiesterase inhibitors on the recovery of urinary function after radical prostatectomy
Dr Yasuhiro Kaiho declared on the Monday 30th May 2016 that they did not have any existing or known future financial relationships or affiliations to disclose (NONE).
Scientific Committee Member